Keyword Suggestion
Domain Informations
Halozyme.com lookup results from whois.godaddy.com server:
- Domain created: 2003-12-08T20:04:28Z
- Domain updated: 2022-09-22T01:20:39Z
- Domain expires: 2025-12-08T20:04:28Z 1 Year, 210 Days left
- Website age: 20 Years, 155 Days
- Registrar Domain ID: 107916827_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS29.DOMAINCONTROL.COM
- NS30.DOMAINCONTROL.COM
Network
- inetnum : 104.237.128.0 - 104.237.159.255
- name : LINODE
- handle : NET-104-237-128-0-2
- status : Reassigned
- created : 2008-04-24
- changed : 2022-12-15
- desc : Geofeed https://ipgeo.akamai.com/linode-geofeed.csv,http://www.linode.com
Owner
- organization : Linode
- handle : LINOD
- address : Array,Philadelphia,PA,19106,US
Abuse
- handle : LAS12-ARIN
- name : Linode Abuse Support
- phone : +1-609-380-7100
- email : [email protected]
Technical support
- handle : LNO21-ARIN
- name : Linode Network Operations
- phone : +1-609-380-7304
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.237.144.180
- Location: Newark United States
- Latitude: 40.739
- Longitude: -74.1697
- Timezone: America/New_York
Site Inspections
Port Scanner (IP: 104.237.144.180)
Spam Check (IP: 104.237.144.180)
Email address with halozyme.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
9. [email protected]
Recent Searched Sites
› Tanie-konto.pl (1 seconds ago) / PL
› Skyservice.pro (24 seconds ago) / UA
› Pstrax.com (31 seconds ago) / US
› Drawnames.com.au (20 seconds ago) / NL
› Qianye88.com (36 seconds ago) / CN
› Catwalk.com.au (13 seconds ago) / US
› Halozyme.com (0 seconds ago) / US
› Wskoczpokase.pl (15 seconds ago) / PL
› 10ofthose.com (2 mins ago) / IE
› Stdclick.com (8 seconds ago) / VN
› Novinykraje.cz (1 seconds ago) / CZ
› Vsedrugoeshop.ru (28 seconds ago) / RU
› Dolc.de (9 seconds ago) / DE
› Hifistudioimport.fi (30 seconds ago) / US
› Chaoscards.co.uk (6 seconds ago) / US
› Emooto.dk (17 seconds ago) / US
› Genesis-international.com (10 seconds ago) / US
› Ceciliaaltieri.com (35 seconds ago) / US
› Divorcewriter.com (1 mins ago) / US
› La-toque-cuivree.fr (6 seconds ago) / FR
Websites Listing
We found Websites Listing below when search with halozyme.com on Search Engine
ENHANZE | Halozyme
To review ENHANZE technology clinical data and published articles, email [email protected]. ... Halozyme’s primary technology is based on its proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20) that degrades hyaluronan, or HA. HA is a glycosaminoglycan, a chain of natural sugars that is a component of normal tissue, …
Halozyme.comHalozyme Therapeutics, Inc. - Resources - Contact Us
Contact Us. Melinda Hutcheon Director, Investor Relations & Corporate Communications 949-266-7029 [email protected] [email protected]
Ir.halozyme.comHalozyme Therapeutics, Inc. - Investor Relations
2022-04-13 · Contact Us. Melinda Hutcheon Director, Investor Relations & Corporate Communications 949-266-7029 [email protected] [email protected]
Ir.halozyme.comHalozyme Therapeutics, Inc. - Resources - Email Alerts
Subscribe To Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription.
Ir.halozyme.comHalozyme Therapeutics, Inc. email format | Halozyme ...
Halozyme therapeutics, inc. uses 2 email formats: 1. (firstname)(l) ([email protected]). Enter a name to find and verify an email
Aeroleads.comHalozyme Therapeutics (NASDAQ:HALO) Rating Lowered to Hold ...
2022-05-12 · Halozyme Therapeutics has a 1 year low of $31.36 and a 1 year high of $46.62. Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) last posted its earnings results on Tuesday, May 10th. The ...
Defenseworld.netHalozyme Therapeutics (NASDAQ:HALO) Downgraded by ...
1 day ago · Halozyme Therapeutics has a fifty-two week low of $31.36 and a fifty-two week high of $46.62. Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) last released its earnings results on Tuesday, May ...
Etfdailynews.comHalozyme Therapeutics (NASDAQ:HALO) Releases FY22 Earnings ...
2 days ago · Posted by admin on May 11th, 2022. Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) updated its FY22 earnings guidance on Tuesday. The company provided EPS guidance of $2.05-2.20 for the period ...
Defenseworld.netFY2022 Earnings Forecast for Halozyme Therapeutics, Inc ...
3 hours ago · HALO opened at $39.04 on Friday. The firm has a 50 day moving average price of $39.66 and a 200 day moving average price of $37.28. The company has a market cap of $5.38 billion, a PE ratio of 13 ...
Defenseworld.netHalozyme Therapeutics (NASDAQ:HALO) Issues FY22 Earnings ...
2 days ago · Posted by MarketBeat News on May 11th, 2022. Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) issued an update on its FY22 earnings guidance on Tuesday morning. The company provided EPS ...
Etfdailynews.comHalozyme Company Profile | Management and Employees List
Find contact information for Halozyme. Learn about their Chemicals & Related Products, Manufacturing market share, competitors, and Halozyme's email format.
Datanyze.comHalozyme Therapeutics, Inc. - Events & Presentations ...
2021-11-02 · Past Presentations. 04/13/2022. Halozyme Transaction Investor Presentation. Download PDF. (opens in new window) 02/22/2022. Fourth Quarter and Full Year 2021 Financial Results Presentation. Download PDF. (opens in new window)
Ir.halozyme.comIs Halozyme Therapeutics (HALO) a Smart Long-Term Buy?
1 day ago · Founded in 1998, Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a San Diego, California-based biotechnology company with a $5.1 billion market capitalization. Halozyme Therapeutics, Inc. (NASDAQ ...
Finance.yahoo.comHalozyme, Inc. Company Profile | San Diego, CA ...
Company Description: Halozyme, Inc. is located in San Diego, CA, United States and is part of the Scientific Research and Development Services Industry. Halozyme, Inc. has 216 total employees across all of its locations and generates $146.69 million in sales (USD). (Sales figure is estimated). There are 3 companies in the Halozyme, Inc ...
Dnb.comHalozyme, Inc. | LinkedIn
Halozyme, Inc. | 14,406 followers on LinkedIn. At Halozyme we continuously push the pace of innovation. | Halozyme is a biopharmaceutical company bringing disruptive solutions to …
Linkedin.comHalozyme Therapeutics Email Format · Verify halozyme.com ...
Ashpool's Preflight system has found 3 email formats for Halozyme Therapeutics, <f><last>@halozyme.com has the highest success rate. Note that different roles may see different success rates, for example the CEO is more likely to have a [email protected]<company>.com address.
Directory.ashpool.ioHalozyme Therapeutics (NASDAQ:HALO) Issues FY 2022 ...
2022-05-10 · Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.05-$2.20 for the period, compared ...
Defenseworld.netHalozyme Therapeutics, Inc. Information | Halozyme ...
Before RocketReach, the process of sourcing email addresses consisted of scouring the internet, asking mutual friends, or stalking on LinkedIn. The most frustrating part was how time consuming this all was.The first time I used RocketReach was when I realized I made the right decision. Finding emails for contacts turned into a one-and-done instead of a week long process.
Rocketreach.coHalozyme Therapeutic (HALO-Q) Profile - The Globe and Mail
See the company profile for Halozyme Therapeutic (HALO-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.
Theglobeandmail.comHalozyme Therapeutics (NASDAQ:HALO) Issues FY 2022 ...
2022-04-20 · Halozyme Therapeutics ( NASDAQ:HALO – Get Rating) updated its FY 2022 earnings guidance on Wednesday. The company provided earnings per share guidance of $2.050-$2.200 for the period, compared ...
Etfdailynews.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| resourceindex.com | namecheap.com | -1 Years, -165 Days |
| floridasunsetgroup.com | namecheap.com | -1 Years, -113 Days |
| creditonestadium.com | tierra.net | -1 Years, -327 Days |
| brightpartnerships.com | ionos.com | -1 Years, -144 Days |
| dexly.pro | namecheap.com | -1 Years, -295 Days |
| alexdesignlab.com | openprovider.com | -1 Years, -340 Days |
| awhonn.org | whois.godaddy.com | 130 Days |
| xledger.net | godaddy.com | 34 Days |
| zallcn.com | xinnet.com | 1 Year, 306 Days |
| lindasharpmda.com | fastdomain.com | 1 Year, 244 Days |